NEUROPHARMACOLOGY OF NE-21610, A NOVEL CAPSAICIN ANALOG

B LYNN , RH COHEN , JN CAMPBELL , RA MEYER
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 198 85 -MEDI

1989
Characterization of the anticonvulsant properties of Ganaxolone (CCD 1042; 3α-hydroxy-3β-methyl-5α-pregnan-20-one), a selective, high-affinity, steroid modulator of the γ-aminobutyric acid(A) receptor

Delia Belelli , Jon E. Hawkinson , Michael B. Bolger , Nancy C. Lan
Journal of Pharmacology and Experimental Therapeutics 280 ( 3) 1284 -1295

200
1997
Response-rate suppression in operant paradigm as predictor of soporific potency in rats and identification of three novel sedative-hypnotic neuroactive steroids.

Kimberly E. Vanover , Nancy C. Lan , Dale M. Edgar , Richard B. Carter
Journal of Pharmacology and Experimental Therapeutics 291 ( 3) 1317 -1323

23
1999
Reversal of behavioral effects of pentylenetetrazol by the neuroactive steroid ganaxolone

Richard B. Carter , Marjolein Beekman , Jeffrey M. Witkin , Jesse T. Ungard
Journal of Pharmacology and Experimental Therapeutics 284 ( 3) 868 -877

55
1998
CCD-3693: an orally bioavailable analog of the endogenous neuroactive steroid, pregnanolone, demonstrates potent sedative hypnotic actions in the rat.

Jon E. Hawkinson , Nancy C. Lan , George Field , Dale M. Edgar
Journal of Pharmacology and Experimental Therapeutics 282 ( 1) 420 -429

63
1997
Anticonvulsant and Behavioral Effects of Neuroactive Steroids Alone and in Conjunction with Diazepam

Richard B. Carter , Jeffrey M. Witkin , Maciej Gasior , Steven R. Goldberg
Journal of Pharmacology and Experimental Therapeutics 282 ( 2) 543 -553

125
1997
Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders

Maciej Gasior , Richard B. Carter , Jeffrey M. Witkin
Trends in Pharmacological Sciences 20 ( 3) 107 -112

264
1999
Discriminative stimulus properties of naloxone

Richard B. Carter , J. David Leander
Psychopharmacology 77 ( 4) 305 -308

26
1982
Pharmacology of 2-[4-(4-Chloro-2-fluorophenoxy)phenyl]-pyrimidine-4-carboxamide: A Potent, Broad-Spectrum State-Dependent Sodium Channel Blocker for Treating Pain States

Victor I. Ilyin , James D. Pomonis , Garth T. Whiteside , James E. Harrison
Journal of Pharmacology and Experimental Therapeutics 318 ( 3) 1083 -1093

32
2006
Topical capsaicin in the treatment of cutaneous disorders

Richard B. Carter
Drug Development Research 22 ( 2) 109 -123

54
1991
Some behavioral effects of repeated d‐amphetamine administrations

Jonathan L. Katz , Jeffrey M. Witkin , Steven I. Dworkin , Linda A. Dykstra
Drug Development Research 20 ( 1) 31 -41

1990
Reinforcing and discriminative stimulus effects of the neuroactive steroids pregnanolone and Co 8-7071 in rhesus monkeys.

James K. Rowlett , Gail Winger , Richard B. Carter , Paul L. Wood
Psychopharmacology 145 ( 2) 205 -212

33
1999
Pharmacological evaluation of a modified conflict procedure: punished drinking in non-water-deprived rats.

Kimberly E. Vanover , Silvia Robledo , Matthew Huber , Richard B. Carter
Psychopharmacology 145 ( 3) 333 -341

23
1999
Neuroactive steroids attenuate cocaine-induced sucrose intake in rats, but not cocaine-induced hyperactivity in mice.

K. E. Vanover , Michael Suruki , Matthew Huber , W. Bryan Wilent
Psychopharmacology 149 ( 3) 269 -276

9
2000
Positive allosteric modulators of the GABA(A) receptor: differential interaction of benzodiazepines and neuroactive steroids with ethanol.

K. E. Vanover , Michael Suruki , Silvia Robledo , Matthew Huber
Psychopharmacology 141 ( 1) 77 -82

64
1999
Acute tolerance to the discriminative stimulus properties of morphine

Jeffrey M. Witkin , Linda A. Dykstra , Richard B. Carter
Pharmacology Biochemistry and Behavior 17 ( 2) 223 -228

16
1982
Blockade of the behavioral effects of 5-HTP by the decarboxylase inhibitor Ro 4-4602

Richard B. Carter , James B. Appel
Pharmacology Biochemistry and Behavior 4 ( 4) 407 -409

16
1976